{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T04:40:20Z","timestamp":1728880820636},"reference-count":14,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,10,13]]},"DOI":"10.7759\/cureus.71393","type":"journal-article","created":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T04:26:02Z","timestamp":1728879962000},"source":"Crossref","is-referenced-by-count":0,"title":["A Case of Plasma Cell Leukemia Arising De Novo: A Rare and Fatal Disease"],"prefix":"10.7759","author":[{"given":"Hisham B","family":"Sweidan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdullah","family":"Jarrah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yating","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2008.4","article-title":"Genetic aberrations and survival in plasma cell leukemia","volume":"22","author":"Tiedemann RE","year":"2008","unstructured":"Tiedemann RE, Gonzalez-Paz N, Kyle RA, et al.. Genetic aberrations and survival in plasma cell leukemia. Leukemia. 2008, 22:1044-52. 10.1038\/leu.2008.4","journal-title":"Leukemia"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000029578","article-title":"Causes of death in primary plasma cell leukemia differ from multiple myeloma: a STROBE-compliant descriptive study based on SEER database","volume":"101","author":"Ge X","year":"2022","unstructured":"Ge X, Meng W, Wang W, Ma H, Zhao S, Cui K. Causes of death in primary plasma cell leukemia differ from multiple myeloma: a STROBE-compliant descriptive study based on SEER database. Medicine (Baltimore). 2022, 101:e29578. 10.1097\/MD.0000000000029578","journal-title":"Medicine (Baltimore)"},{"key":"ref3","doi-asserted-by":"crossref","DOI":"10.1016\/S0889-8588(05)70125-8","article-title":"Nonsecretory myeloma, immunoglobulin D myeloma, and plasma cell leukemia","volume":"13","author":"Blad\u00e9 J","year":"1999","unstructured":"Blad\u00e9 J, Kyle RA. Nonsecretory myeloma, immunoglobulin D myeloma, and plasma cell leukemia. Hematol Oncol Clin North Am. 1999, 13:1259-72.","journal-title":"Hematol Oncol Clin North Am"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.22.01226","article-title":"More than 2% of circulating tumor plasma cells defines plasma cell leukemia-like multiple myeloma","volume":"41","author":"Jelinek T","year":"2023","unstructured":"Jelinek T, Bezdekova R, Zihala D, et al.. More than 2% of circulating tumor plasma cells defines plasma cell leukemia-like multiple myeloma. J Clin Oncol. 2023, 41:1383-92. 10.1200\/JCO.22.01226","journal-title":"J Clin Oncol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2012.336","article-title":"Plasma cell leukemia: consensus statement on diagnostic requirements, response criteria and treatment recommendations by the International Myeloma Working Group","volume":"27","author":"Fern\u00e1ndez de Larrea C","year":"2013","unstructured":"Fern\u00e1ndez de Larrea C, Kyle RA, Durie BG, et al.. Plasma cell leukemia: consensus statement on diagnostic requirements, response criteria and treatment recommendations by the International Myeloma Working Group. Leukemia. 2013, 27:780-91. 10.1038\/leu.2012.336","journal-title":"Leukemia"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2016.158303","article-title":"Prognostic impact of circulating plasma cells in patients with multiple myeloma: implications for plasma cell leukemia definition","volume":"102","author":"Granell M","year":"2017","unstructured":"Granell M, Calvo X, Garcia-Gui\u00f1\u00f3n A, et al.. Prognostic impact of circulating plasma cells in patients with multiple myeloma: implications for plasma cell leukemia definition. Haematologica. 2017, 102:1099-104. 10.3324\/haematol.2016.158303","journal-title":"Haematologica"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(87)90942-9","article-title":"Plasma cell leukemia: an evaluation of response to therapy","volume":"83","author":"Noel P","year":"1987","unstructured":"Noel P, Kyle RA. Plasma cell leukemia: an evaluation of response to therapy. Am J Med. 1987, 83:1062-8. 10.1016\/0002-9343(87)90942-9","journal-title":"Am J Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1994.tb05114.x","article-title":"Primary plasma cell leukaemia","volume":"88","author":"Dimopoulos MA","year":"1994","unstructured":"Dimopoulos MA, Palumbo A, Delasalle KB, Alexanian R. Primary plasma cell leukaemia. Br J Haematol. 1994, 88:754-9. 10.1111\/j.1365-2141.1994.tb05114.x","journal-title":"Br J Haematol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-018-0209-7","article-title":"European myeloma network recommendations on diagnosis and management of patients with rare plasma cell dyscrasias","volume":"32","author":"Gavriatopoulou M","year":"2018","unstructured":"Gavriatopoulou M, Musto P, Caers J, et al.. European myeloma network recommendations on diagnosis and management of patients with rare plasma cell dyscrasias. Leukemia. 2018, 32:1883-98. 10.1038\/s41375-018-0209-7","journal-title":"Leukemia"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2007.06921.x","article-title":"Sustained complete remissions in multiple myeloma linked to bortezomib in total therapy 3: comparison with total therapy 2","volume":"140","author":"Pineda-Roman M","year":"2008","unstructured":"Pineda-Roman M, Zangari M, Haessler J, et al.. Sustained complete remissions in multiple myeloma linked to bortezomib in total therapy 3: comparison with total therapy 2. Br J Haematol. 2008, 140:625-34. 10.1111\/j.1365-2141.2007.06921.x","journal-title":"Br J Haematol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1080\/10428190500520954","article-title":"Bortezomib is effective in primary plasma cell leukemia","volume":"47","author":"Finnegan DP","year":"2006","unstructured":"Finnegan DP, Kettle P, Drake M, et al.. Bortezomib is effective in primary plasma cell leukemia. Leuk Lymphoma. 2006, 47:1670-3. 10.1080\/10428190500520954","journal-title":"Leuk Lymphoma"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.24700","article-title":"Primary plasma cell leukemia: a surveillance, epidemiology, and end results database analysis between 1973 and 2004","volume":"115","author":"Ramsingh G","year":"2009","unstructured":"Ramsingh G, Mehan P, Luo J, Vij R, Morgensztern D. Primary plasma cell leukemia: a surveillance, epidemiology, and end results database analysis between 1973 and 2004. Cancer. 2009, 115:5734-9. 10.1002\/cncr.24700","journal-title":"Cancer"},{"key":"ref13","article-title":"Primary plasma cell leukaemia in a 39-year-old man","volume":"13","author":"Kasinathan G","year":"2020","unstructured":"Kasinathan G. Primary plasma cell leukaemia in a 39-year-old man. BMJ Case Reports CP. 2020, 13:235543.","journal-title":"BMJ Case Reports CP"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.5045\/br.2022.2022033","article-title":"Update on primary plasma cell leukemia","volume":"57","author":"Jung SH","year":"2022","unstructured":"Jung SH, Lee JJ. Update on primary plasma cell leukemia. Blood Res. 2022, 57:62-6. 10.5045\/br.2022.2022033","journal-title":"Blood Res"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/261983-a-case-of-plasma-cell-leukemia-arising-de-novo-a-rare-and-fatal-disease","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T04:26:03Z","timestamp":1728879963000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/261983-a-case-of-plasma-cell-leukemia-arising-de-novo-a-rare-and-fatal-disease"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,13]]},"references-count":14,"URL":"https:\/\/doi.org\/10.7759\/cureus.71393","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10,13]]}}}